amivantamab
janssen,genmab
['lcsm,(-blcsm)', 'lung', 'sclc', 'nsclc', 'chrysalis,(-chrysalis2),(-chrysalis-2),(-chrysalis 2)']
#asco22 day 1: #lungcancer highlights 4/6 #chrysalis #amivantamab (dual egfr/met inhibitor) on #metex14 nsclc n=55 1l=9, no prior met tki =18, prior met tki=28 orrs = 57/47/17% (higher in il) diff mech of action and aes than tkis
#lcsm 
Associate Director Community Outreach- Thoracic Oncology-University of Miami @SylvesterCancer , Boricua en la Luna, Tweets are my own. (she/her)